EX-32.2 5 w68537exv32w2.htm EXHIBIT 32.2 exv32w2
 

Exhibit 32.2

CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

     In connection with the Quarterly Report of Novavax, Inc. (the “Company”) on Form 10-Q for the period ended September 30, 2004 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Dennis W. Genge, Vice-President and Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

  1)   The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
 
  2)   The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

     
  By: /s/ Dennis W. Genge
  Name: Dennis W. Genge
  Title: Vice President and
             Chief Financial Officer
 
   
  November 8, 2004